HNGE Stock Analysis: Buy, Sell, or Hold?
HNGE - Hinge Health, Inc.
$34.90
-1.32 (-3.64%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 10, 2026
9d
Get Alerted When HNGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: HNGE is down 18.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: HNGE is down 18.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.57
Based on 11.4% avg growth
INTRINSIC VALUE TODAY
$19.60
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HNGE is currently trading at $34.90, which is considered oversold relative to its 30-day fair value range of $40.62 to $48.67. From a valuation perspective, the stock is trading at a discount (Forward PE: 48.8) compared to its historical average (61.9). Remarkably, the market is currently pricing in an annual earnings decline of 7.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HNGE is in a downtrend. The price is currently testing key support at $34.15. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $46.00 (+27.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HNGE is in a downtrend. The price is currently testing key support at $34.15. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $46.00 (+27.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$40.62 -
$48.67
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding HNGE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.6%)
- BULLISH: Trading 27.0% below Wall St target ($46.00)
- WARNING: Recommendation downgraded due to -18.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$40.62 -
$48.67
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$34.15
Resistance Level
$44.08
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
48.83
Wall Street Target
$46.00
(+27.0%)
Revenue Growth (YoY)
49.7%
Profit Margin
7.3%
Valuation Discount vs History
-7.6% cheaper
PE vs Historical
48.8 vs 61.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.6%
(market-implied from PE analysis)
1-Year Target
$33.47
(-8%)
2-Year Target
$30.92
(-15%)
3-Year Target
$28.57
(-21%)
3-Yr Target (if PE normalizes)
(PE: 49→62)
$36.22
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 48.8, Growth: 18.7%)
$60.59
(+67%)
Base:
(SPY PE: 22.3, Growth: 18.7%)
$27.67
(-24%)
Bear:
(PE: 19.0, Growth: 18.7%)
$23.52
(-35%)
📈
Valuation based on Current Earnings
Trailing PE: 27.16 | Current EPS (TTM): $1.74
Bull Case
$25.99
(-26%)
Analyst growth -50.0%, PE expands to 29.9
Base Case
$23.63
(-32%)
Market implied -50.0%, PE stable at 27.2
Bear Case
$32.14
(-8%)
Severe decline -20.0%, PE contracts to 23.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 48.8 to 61.9
Stabilization Target:
$45.92
(+26.8%)
PE Expansion Potential:
+26.8%
Last updated: January 31, 2026 1:05 AM ET
Data refreshes hourly during market hours. Next update: 2:05 AM
Data refreshes hourly during market hours. Next update: 2:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HNGE showing a specific setup today?
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$310 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 57 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$29 | 48 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 55 HOLD |
Advanced HNGE Option Strategies
Professional options setups generated by AI based on today's HNGE price and gamma walls.